Home › Therapeutic areas › Cardiovascular › Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (4 companies)
Companies with an active program in Pulmonary Arterial Hypertension.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio | Cardiovascular Rare | 2 | NDA Submitted | — | 4 |
| INSM | Insmed | CardiovascularImmunology+3 Rare | 1 | Approved | $25.1B | 15 |
| LQDA | Liquidia | CardiovascularImmunology+1 Rare | 4 | Approved | $3.97B | 9 |
| RVPH | Reviva Pharmaceuticals | CardiovascularDermatology+2 Rare | 1 | Phase 3 | $4.8M | 10 |
No companies match.